SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
107 PDLI gets an upgrade from Paine Webber... they go to a "buy". DAK LLCF-5/10/1999
106 And here's the first quarter results: biz.yahoo.com Cash position lookingLLCF-5/6/1999
105 Supporting link... prnewswire.comHIA-4/14/1999
104 In the third quarter of '98 Genentech signed licensing and royalty agreemenHIA-4/14/1999
103 PDLI picked up a reco from William Tanner at Vector securites. DAK LLCF-4/13/1999
102 Many of these bio-tech companies are working in different areas...so successfulHIA-4/7/1999
101 Please check out this information. Your comments pro or con will be welcomed.aknahow-4/7/1999
100 <.Run the numbers as a percentage of sales...say $100 million in sales and LLCF-4/7/1999
99 Roche does development (new trials), manufacturing, marketing, and distributionHIA-4/7/1999
98 While I'm at it... does anyone know exactly what the deal is with Roche forLLCF-4/7/1999
97 <sales of $150 million... 25% profit margin and that's $38 million... sLLCF-4/7/1999
96 It appears that Zenapax (for Kidney transplants) can expect U.S. sales of $75 mHIA-4/6/1999
95 <.They have revenue from sales of Zenapax > <.and actually Zenapax isLLCF-4/5/1999
94 And there is now an effective phase II Zenapax trial for use against bone marroHIA-3/25/1999
93 -- Roche/Zenapax -2: Annual Sales Of CHF100M Seen >Z.ROC -- BASEL (Dow JonCIN-CIU-E-3/4/1999
92 The revenue for the fourth quarter minus interest income is 13% more than the rHIA-3/3/1999
91 Another week has gone by and the stock price is even lower. Someone must know Phil Placier-3/3/1999
90 The stock had just run up to 26...so a pull-back would not be unexpected...the HIA-2/24/1999
89 Any ideas why the stock price has decreased almost %30 since the first of the yPhil Placier-2/24/1999
88 PDLI has a small number of shares...over $140 million in cash...and a commerciaHIA-2/23/1999
87 The quotes below indicate it is still an independent company. Apparently justaknahow-12/28/1998
86 George I just ordered into this site and notice there has been no activity sinSPSEIFERT-12/28/1998
85 Peter, thanks for the input but it was not my intention to discuss XOMA the staknahow-6/18/1998
84 The chart of XOMA follows the trend of PDLI and the Biotech index for the last fut_trade-6/18/1998
83 Ralf, I do not know why, but on the 15 th. XOMA announced a HE patent that somaknahow-6/17/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News